Mirum Pharmaceuticals, Inc. logo MIRM - Mirum Pharmaceuticals, Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 1
BUY 17
HOLD 0
SELL 0
STRONG
SELL 0
| PRICE TARGET: $142.55 DETAILS
HIGH: $185.00
LOW: $118.00
MEDIAN: $140.00
CONSENSUS: $142.55
UPSIDE: 44.54%

Profitability Ratios

Ratio Value
GP Margin 80.7%
EBIT Margin -1.4%
EBITDA Margin 3.3%
Operating Margin -4.2%
Pretax Margin -4.1%
Cont. Ops Margin -4.5%
Net Margin -4.5%
Bottom Line Margin -4.5%

Liquidity Ratios

Ratio Value
Current Ratio 2.67
Quick Ratio 2.55
Solvency Ratio 0.002
Cash Ratio 1.44

Valuation Ratios

Ratio Value
Price/Earnings
-169.72
Peers avg: 32.8
PEG Ratio 2.28
Forward PEG 2.28
Price/Book 12.60
Price/Sales 7.61
Price/FCF 72.26
Price/Op Cash Flow 71.03

Debt Ratios

Ratio Value
Debt/Assets 0.3790
Debt/Equity 1.0151
Debt/Capital 0.5038
Long-Term Debt/Capital 0.4961
Financial Leverage 2.68

Cash Flow Ratios

Ratio Value
Working Capital Turnover 1.71
Operating Cash Flow Ratio 0.271
Operating Cash Flow/Sales 10.7%
Free Cash Flow/Operating Cash Flow 98.3%

Coverage Ratios

Ratio Value
Debt Service Coverage 0.92
Interest Coverage -1.5384
Short-Term Operating Cash Flow Coverage 26.10
Operating Cash Flow Coverage 0.17
Capital Expenditure Coverage 58.52
Dividend + Capital Expenditure Coverage 58.52

Dividend Ratios

Ratio Value
Payout Ratio 0.0000%
Dividend Yield 0.0000%
Dividend Yield % 0.0000%
Dividend Per Share 0.0000

Per Share Ratios

Ratio Value
Revenue/Share 10.39
EPS -0.465
Debt/Share 6.6504
Cash/Share 7.64
Book Value/Share 6.27
Tangible BV/Share 1.07
Equity/Share 6.27
Operating Cash Flow/Share 1.112
Capital Expenditure/Share 0.019
FCF/Share 1.093

Other Ratios

Ratio Value
Net Income/Earnings Before Tax 1.090
Earnings Before Tax/EBIT 0.968
Price/Fair Value 12.60
Debt/Market Cap 0.0787
Effective Tax Rate -9.0%
Enterprise Value Multiple 231.78